Neuroimmunology: an expanding frontier in autoimmunity.

PubWeight™: 0.93‹?›

🔗 View Article (PMC 4413830)

Published in Front Immunol on April 29, 2015

Authors

Romana Höftberger1

Author Affiliations

1: Institute of Neurology, Medical University of Vienna , Vienna , Austria.

Articles cited by this

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol (2013) 11.47

Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol (2009) 5.75

AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol (2009) 4.49

A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol (2014) 4.37

Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol (2013) 4.18

Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis. Ann Neurol (2014) 3.40

Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol (2014) 2.07

Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol (2012) 1.80

Autoimmune encephalopathies. Ann N Y Acad Sci (2014) 1.65

Clinical relevance of serum antibodies to extracellular N-methyl-D-aspartate receptor epitopes. J Neurol Neurosurg Psychiatry (2014) 1.55

Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci (2013) 1.48

Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies. Neurology (2014) 1.26

Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers. Nat Rev Neurol (2014) 1.06

Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response. JAMA Neurol (2015) 1.00

When a serum test overrides the clinical assessment. Neurology (2015) 0.94